Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
535.17
+10.65 (2.03%)
At close: Oct 22, 2026, 4:00 PM EDT
536.03
+0.86 (0.16%)
After-hours: Oct 22, 2026, 4:45 PM EDT

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had revenue of $3.33B in the quarter ending June 30, 2026, with 12.45% growth. This brings the company's total for the last twelve months to $12.59B, up 10.23% year-over-year. In the year 2025, Vertex Pharmaceuticals had annual revenue of $12.00B with 8.90% growth. That makes Vertex Pharmaceuticals the 1,202nd largest company in the world by revenue and 383rd in the United States.

Revenue (ttm)
$12.59B
Revenue Growth
+10.23%
P/S Ratio
10.77
Revenue / Employee
$1,966,750
Employees
6,400
Market Cap
135.64B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Trikafta / Kaftrio 10.31B 85.9%
  • Alyftrek 837.80M 7.0%
  • Other 644.70M 5.4%
  • Casgevy 115.80M 1.0%
  • Journavx 59.60M 0.5%
  • Other Collaborative and Royalty 30.70M 0.3%

By Geography

Chart
  • United States Product 7.55B 62.7%
  • Outside of United States Product 4.45B 37.0%
  • Other Collaborative and Royalty 30.70M 0.3%
Fiscal year ended Dec 31, 2025 See the full Vertex Pharmaceuticals breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.00B981.20M8.90%
Dec 31, 202411.02B1.15B11.66%
Dec 31, 20239.87B938.50M10.51%
Dec 31, 20228.93B1.36B17.91%
Dec 31, 20217.57B1.37B22.06%
Dec 31, 20206.21B2.04B49.08%
Dec 31, 20194.16B1.12B36.59%
Dec 31, 20183.05B558.95M22.46%
Dec 31, 20172.49B786.48M46.20%
Dec 31, 20161.70B669.84M64.89%
Dec 31, 20151.03B451.92M77.86%
Dec 31, 2014580.42M-631.56M-52.11%
Dec 31, 20131.21B-315.07M-20.63%
Dec 31, 20121.53B116.42M8.25%
Dec 31, 20111.41B1.27B883.91%
Dec 31, 2010143.37M41.48M40.71%
Dec 31, 2009101.89M-73.62M-41.94%
Dec 31, 2008175.50M-23.51M-11.81%
Dec 31, 2007199.01M-17.34M-8.02%
Dec 31, 2006216.36M55.47M34.47%
Dec 31, 2005160.89M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.